Home Cart Sign in  
Chemical Structure| 112006-57-2 Chemical Structure| 112006-57-2

Structure of 112006-57-2

Chemical Structure| 112006-57-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 112006-57-2 ]

CAS No. :112006-57-2
Formula : C15H16N2OS
M.W : 272.37
SMILES Code : O=C(N(C)C)C1=C(SCC2=CC=CC=C2)N=CC=C1
MDL No. :MFCD08316155
InChI Key :MPGOCEUHZWEFJX-UHFFFAOYSA-N
Pubchem ID :11086903

Safety of [ 112006-57-2 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Computational Chemistry of [ 112006-57-2 ] Show Less

Physicochemical Properties

Num. heavy atoms 19
Num. arom. heavy atoms 12
Fraction Csp3 0.2
Num. rotatable bonds 5
Num. H-bond acceptors 2.0
Num. H-bond donors 0.0
Molar Refractivity 78.34
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

58.5 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

2.23
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

2.65
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

2.92
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

2.26
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

2.92
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

2.6

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-3.34
Solubility 0.126 mg/ml ; 0.000462 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-3.53
Solubility 0.0805 mg/ml ; 0.000295 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-5.12
Solubility 0.00208 mg/ml ; 0.00000764 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Moderately soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

Yes
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

Yes
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

Yes
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.08 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

0.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<0.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

2.5

Application In Synthesis of [ 112006-57-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 112006-57-2 ]

[ 112006-57-2 ] Synthesis Path-Downstream   1~4

  • 2
  • [ 52943-21-2 ]
  • [ 100-53-8 ]
  • [ 112006-57-2 ]
YieldReaction ConditionsOperation in experiment
In N-methyl-acetamide; water; EXAMPLE 1 N,N-Dimethyl-2-(phenylmethylthio)-3-pyridinecarboxamide A solution of 25.0 g (223 mmol) of potassium t-butoxide in 100 ml of dimethylformamide was cooled to 0 C. and 22 ml (186 mmol) of benzyl mercaptan added dropwise at 0 C. After addition was complete, the reaction mixture was allowed to warm to 25 C. and stirred at this temperature for 15 minutes. The reaction mixture was then re-cooled to O C. and 34.0 g (186 mmol) of N,N-dimethyl-2-(chloro)-3-pyridinecarboxamide added in one portion. After an exotherm to 50 C., the mixture was heated at 80 C. for 1.5 hour. The mixture was cooled, poured into 100 ml of water and extracted with ether. The combined organic extracts were washed twice with water, then brine and dried over sodium sulfate. Concentration gave 19.2 g of a viscous yellow oil. IR (Nujol) 1640 (CONMe2) cm-1. NMR (CDCl3): delta2.72 (s, 3H, NCH3); 3.04 (s, 3H, NCH3); 4.49 (s, 2H, SCH2 C6 H5); 6.97-7.17 (m, 1H); 7.18-7.57 (m, 6H); and 8.50 (d of d, 1H).
In N-methyl-acetamide; water; EXAMPLE 1 N,N-Dimethyl-2-(phenylmethylthio)-3-pyridinecarboxamide A solution of 25.0 g (223 mmol) of potassium t-butoxide in 100 ml of dimethylformamide was cooled to 0 C. and 22 ml (186 mmol) of benzyl mercaptan added dropwise at 0 C. After addition was complete, the reaction mixture was allowed to warm to 25 C. and stirred at this temperature for 15 minutes. The reaction mixture was then re-cooled to 0 C. and 34.0 g (186 mmol) of N,N-dimethyl-2-(chloro)-3-pyridinecarboxamide added in one portion. After an exotherm to 50 C., the mixture was heated at 80 C. for 1.5 hour. The mixture was cooled, poured into 100 ml of water and extracted with ether. The combined organic extracts were washed twice with water, then brine and dried over sodium sulfate. Concentration gave 19.2 g of a viscous yellow oil. IR (Nujol) 1640 (CONMe2) cm-1. NMR (CDCl3): delta 2.72 (s, 3H, NCH3); 3.04 (s, 3H, NCH3); 4.49 (s, 2H, SCH2 C6 H5); 6.97-7.17 (m, 1H); 7.18-7.57 (m, 6H); and 8.50 (d of d, 1H).
  • 3
  • [ 112006-57-2 ]
  • [ 112006-75-4 ]
YieldReaction ConditionsOperation in experiment
With hydrogenchloride; sodium hypochlorite; ammonia; In dichloromethane; water; EXAMPLE 2 N,N-Dimethyl-2-aminosulfonyl-3-pyridinecarboxamide A mixture of 4.4 ml of concentrated hydrochloric acid, 66 ml of methylene chloride, 34 ml of water and 4.0 g (14.7 mmol) of the <strong>[112006-57-2]N,N-dimethyl-2-(phenylmethylthio)-3-pyridinecarboxamide</strong> was cooled to 0 C. Maintaining a temperature of -5 to 3 C., 60 ml (40.5 mmol) of 5% sodium hypochlorite was added dropwise over 15 minutes. The resulting yellow emulsion was stirred at 0 C. an additional 20 minutes. The reaction mixture was then poured into water and extracted with methylene chloride. The combined organic extracts were kept at 0 C. and washed with a saturated sodium bisulfite solution and dried over sodium sulfate. After 30 minutes, the yellow solution was filtered into a reaction flask and cooled to -78 C. and 5 ml (431 mmol) of dry ammonia added. The reaction mixture was allowed to warm to room temperature and the solvent removed under reduced pressure. The resulting solid was slurried with 5 ml of water and the insoluble white solid collected by filtration to provide 2.0 g of the subject compound, m.p. 198-209 C.(d). NMR (DMSO): delta 2.70 (s, 3H, NCH3); 2.93 (s, 3H, NCH3); 7.60-7.75 (m, 1H); 7.90 (m, 1H); and 8.75 (m, 1H).
  • 4
  • [ 112811-90-2 ]
  • [ 112811-91-3 ]
  • [ 112006-57-2 ]
YieldReaction ConditionsOperation in experiment
52.1 parts (93.9%) With thionyl chloride; dimethyl amine; In water; ethyl acetate; EXAMPLE 5 N,N-Dimethyl-2-(phenylmethylthio)-3-pyridinecarboxamide A mixture of 29.7 parts of thionylchloride, 50.0 parts of 2-(phenylmethylthio)-3-pyridinecarboxylic acid, and 225 parts of ethyl acetate was refluxed for 1.6 hours. The resulting solution of 2-(phenylmethylthio)-3-pyridinecarbonyl chloride was cooled to 5 C. While maintaining the temperature at approximately 10 C., 70 parts of 40% dimethylamine in water were added. The pH was adjusted to 4.0 with 36% HCl and the lower aqueous layer was decanted. Water was added to the ethyl acetate layer and the resulting mixture was distilled until the ethyl acetate was removed. After cooling and seeding, N,N-dimethyl-2-(phenylmethylthio)-3-pyridinecarboxamide was recovered by filtration, washed with water, and dried. This gave 52.1 parts (93.9%), melting point 61-63 C.
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 112006-57-2 ]

Aryls

Chemical Structure| 18184-75-3

A283122 [18184-75-3]

6-Benzyl-5,7-dihydro-5,7-dioxopyrrolo[3,4-b]pyridine

Similarity: 0.57

Chemical Structure| 10177-15-8

A146639 [10177-15-8]

5-Phenylnicotinamide

Similarity: 0.56

Chemical Structure| 1129403-56-0

A307810 [1129403-56-0]

N-(2-(Diethylamino)ethyl)-2,4-dimethyl-5-((2-oxo-5-(2-phenylthiazol-4-yl)indolin-3-ylidene)methyl)-1H-pyrrole-3-carboxamide

Similarity: 0.56

Chemical Structure| 3034-31-9

A151802 [3034-31-9]

N-Phenyl isonicotinicamide

Similarity: 0.55

Chemical Structure| 1290541-46-6

A827549 [1290541-46-6]

(E)-3-Benzyl-2-(2-(pyridin-3-yl)vinyl)quinazolin-4(3H)-one

Similarity: 0.54

Amides

Chemical Structure| 108831-66-9

A196063 [108831-66-9]

6-Methyl-3H-thieno[2,3-d]pyrimidin-4-one

Similarity: 0.67

Chemical Structure| 18593-44-7

A200245 [18593-44-7]

5,6-Dimethylthieno[2,3-d]pyrimidin-4(3H)-one

Similarity: 0.66

Chemical Structure| 371206-03-0

A306688 [371206-03-0]

2-(4-Oxo-4,5,6,7-tetrahydro-3H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-3-yl)acetic acid

Similarity: 0.63

Chemical Structure| 14080-50-3

A123468 [14080-50-3]

Thieno[2,3-d]pyrimidin-4(3H)-one

Similarity: 0.62

Chemical Structure| 910656-00-7

A213933 [910656-00-7]

4-Amino-N-methylnicotinamide

Similarity: 0.60

Amines

Chemical Structure| 910656-00-7

A213933 [910656-00-7]

4-Amino-N-methylnicotinamide

Similarity: 0.60

Chemical Structure| 51486-03-4

A586086 [51486-03-4]

2-Amino-5-methylthiophene-3-carboxamide

Similarity: 0.60

Chemical Structure| 54864-83-4

A140133 [54864-83-4]

6-Chloro-N,N-dimethylnicotinamide

Similarity: 0.60

Chemical Structure| 6265-73-2

A307951 [6265-73-2]

N-(2-Hydroxyethyl)nicotinamide

Similarity: 0.59

Chemical Structure| 4815-28-5

A113460 [4815-28-5]

2-Amino-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide

Similarity: 0.58

Sulfides

Chemical Structure| 15908-63-1

A118634 [15908-63-1]

2-Methyl-4-(methylthio)-6-oxo-1,6-dihydropyrimidine-5-carbonitrile

Similarity: 0.55

Related Parent Nucleus of
[ 112006-57-2 ]

Pyridines

Chemical Structure| 910656-00-7

A213933 [910656-00-7]

4-Amino-N-methylnicotinamide

Similarity: 0.60

Chemical Structure| 54864-83-4

A140133 [54864-83-4]

6-Chloro-N,N-dimethylnicotinamide

Similarity: 0.60

Chemical Structure| 6265-73-2

A307951 [6265-73-2]

N-(2-Hydroxyethyl)nicotinamide

Similarity: 0.59

Chemical Structure| 29876-14-0

A124827 [29876-14-0]

N-(2-(1H-Indol-3-yl)ethyl)nicotinamide

Similarity: 0.57

Chemical Structure| 34562-97-5

A486869 [34562-97-5]

3-((3-Carboxypropyl)carbamoyl)pyridine

Similarity: 0.57